4.7 Review

A roadmap to pulmonary delivery strategies for the treatment of infectious lung diseases

期刊

JOURNAL OF NANOBIOTECHNOLOGY
卷 20, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s12951-022-01307-x

关键词

Drug delivery; Lung; Pulmonary infectious disease; Targeting; Therapeutic strategies

资金

  1. National Natural Science Foundation of China [81773654]
  2. 111 Project [B18035]
  3. Fundamental Research Funds for the Central Universities
  4. Sichuan University College Student Innovation and Entrepreneurship Training Program

向作者/读者索取更多资源

Pulmonary drug delivery is an important approach for treating infectious lung diseases, with unique advantages. This review article examines literature on pulmonary delivery strategies in the past decade, offering new perspectives for future treatments.
Pulmonary drug delivery is a highly attractive topic for the treatment of infectious lung diseases. Drug delivery via the pulmonary route offers unique advantages of no first-pass effect and high bioavailability, which provides an important means to deliver therapeutics directly to lung lesions. Starting from the structural characteristics of the lungs and the biological barriers for achieving efficient delivery, we aim to review literatures in the past decade regarding the pulmonary delivery strategies used to treat infectious lung diseases. Hopefully, this review article offers new insights into the future development of therapeutic strategies against pulmonary infectious diseases from a delivery point of view.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据